UNSPSC 51283111: Cuprimyxin

This classification denotes a topical anti-infective agent with the molecular formula 2C13H9N2O4.Cu, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q728680892, chemically known as copper, bis(6-methoxy-1-phenazinol 5,10-dioxidato-o(sup1),o(sup10))- but more generally known as cuprimyxin, which bears US NIH Compound Identifier 421620. European Medicines Agency schedules Cuprimyxin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06833MIG.

UNSPSC 51283111 Cuprimyxin is a Commodity code that does not map to the recent state and local solicitations tagged under it. The code nominally describes a specific antibiotic pharmaceutical product, but the four recent opportunities in the record—covering naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, fire department medical and first aid supplies, and generic multi-source pharmaceuticals through cooperative purchasing—span a broad range of health-related goods and services with no apparent connection to cuprimyxin specifically. The mismatch suggests either miscoding in the source data or a systematic tagging issue affecting this code's reliability for procurement intelligence.

Because the recent opportunities tagged under this code are not materially related to cuprimyxin procurement, the code shows little actionable activity for vendors supplying that product. Firms pursuing state and local cuprimyxin contracts should rely on direct market surveillance and vendor relationship management rather than UNSPSC code monitoring, as the classification does not reliably surface actual buying signals.